These nine companies are working on coronavirus treatments or vaccines — here’s where things stand – MarketWatch

“Big Pharma,” as the panderers on the left like to call them, will be the ones to develop treatments and vaccines for the Coronavirus. Socialized medicine advocates demonize this industry at every opportunity because they are such an easy target. But the fact is that government run health care, whether it is called Medicare for All, Obamacare or some form of single payer plan, would eviscerate this industry. Without a vibrant, innovative and profitable pharmaceutical industry, outbreaks like this would be far more deadly.

A mix of legacy drugmakers and small startups have stepped forward with plans to develop vaccines or treatments that target the infection caused by the novel coronavirus. COVID-19, which was first detected in December in Wuhan, China, has sickened more than 100,000 people worldwide and killed at least 3,400. There are no Food and Drug Administration-approved vaccines or therapies for the disease. Read more of MarketWatch’s coverage of COVID-19. In the U.S., the companies that are initiating development have received funding from two organizations: the Biomedical Advanced Research and Development Authority (BARDA), which is a division of the Department of Health and Human Services, and the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health. Some companies have received funding from Coalition for Epidemic Preparedness Innovations (CEPI), a global organization based in Oslo. Other companies are funding trials by themselves or through partnerships with other life sciences companies.

These nine companies are working on coronavirus treatments or vaccines — here’s where things stand – MarketWatch